التفاصيل البيبلوغرافية
| العنوان: |
Corrigendum to “The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.” Kidney Int. 2021;100:225–237 |
| المؤلفون: |
Ariceta, Gema, Dixon, Bradley P., Kim, Seong Heon, Kapur, Gaurav, Mauch, Teri, Ortiz, Stephan, Vallee, Marc, Denker, Andrew E., Kang, Hee Gyung, Greenbaum, Larry A., Lovell, Helen, Muff-Luett, Melissa, Malone, Kristin, Adeagbo, Oluwasegun, Wilkerson, Alexandria, Fraga, Gloria, Sarri, Scherezade, Cheong, Hae Il, Ahn, Yo Han, Han, Kyoung Hee, Wühl, Elke, Ardissino, Gianluigi, Capone, Valentina, Constantinescu, Alexandru, Boydstun, Ivy, Raafat, Reem, Mersha, Marezhe, Wandique-Rapalo, Belkis, Hataya, Hiroshi, Hamada, Terano, Rees, Lesley, Pose, Araceli Garcia, Pérez, Inés Vergara, Vilariño, Mercedes Cao, Adams, Brigitte, Nathalie, Tram |
| المصدر: |
Kidney International ; volume 104, issue 1, page 205 ; ISSN 0085-2538 |
| بيانات النشر: |
Elsevier BV |
| سنة النشر: |
2023 |
| المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: |
Nephrology |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1016/j.kint.2023.04.010 |
| الإتاحة: |
https://doi.org/10.1016/j.kint.2023.04.010Test
https://api.elsevier.com/content/article/PII:S0085253823003186?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0085253823003186?httpAccept=text/plainTest |
| حقوق: |
https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: |
edsbas.DCF1681F |
| قاعدة البيانات: |
BASE |
